View in EDS

Efficacy and safety of beinaglutide with continuous subcutaneous infusion in newly diagnosed patients with type 2 diabetes: a randomized, control, open-labeled clinical trial.

Saved in:
Bibliographic Details
Title: Efficacy and safety of beinaglutide with continuous subcutaneous infusion in newly diagnosed patients with type 2 diabetes: a randomized, control, open-labeled clinical trial.
Authors: Luo Y; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China., Ding B; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China., Xia WQ; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China., Liu BL; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China., Ge SH; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China., Yuan L; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China. happy_yuanlu@126.com., Ma JH; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China. majianhua196503@126.com.
Source: Journal of endocrinological investigation [J Endocrinol Invest] 2025 Nov; Vol. 48 (11), pp. 2703-2711. Date of Electronic Publication: 2025 Jul 28.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1720-8386 (Electronic) Linking ISSN: 03914097 NLM ISO Abbreviation: J Endocrinol Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40719951
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of beinaglutide with continuous subcutaneous infusion in newly diagnosed patients with type 2 diabetes: a randomized, control, open-labeled clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Luo+Y%22">Luo Y</searchLink>; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China.<br /><searchLink fieldCode="AU" term="%22Ding+B%22">Ding B</searchLink>; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China.<br /><searchLink fieldCode="AU" term="%22Xia+WQ%22">Xia WQ</searchLink>; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China.<br /><searchLink fieldCode="AU" term="%22Liu+BL%22">Liu BL</searchLink>; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China.<br /><searchLink fieldCode="AU" term="%22Ge+SH%22">Ge SH</searchLink>; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China.<br /><searchLink fieldCode="AU" term="%22Yuan+L%22">Yuan L</searchLink>; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China. happy_yuanlu@126.com.<br /><searchLink fieldCode="AU" term="%22Ma+JH%22">Ma JH</searchLink>; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210000, China. majianhua196503@126.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806594%22">Journal of endocrinological investigation</searchLink> [J Endocrinol Invest] 2025 Nov; Vol. 48 (11), pp. 2703-2711. <i>Date of Electronic Publication: </i>2025 Jul 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>7806594 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1720-8386 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203914097%22">03914097 </searchLink><i>NLM ISO Abbreviation: </i>J Endocrinol Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40719951
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40618-025-02665-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2703
    Titles:
      – TitleFull: Efficacy and safety of beinaglutide with continuous subcutaneous infusion in newly diagnosed patients with type 2 diabetes: a randomized, control, open-labeled clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Luo Y
      – PersonEntity:
          Name:
            NameFull: Ding B
      – PersonEntity:
          Name:
            NameFull: Xia WQ
      – PersonEntity:
          Name:
            NameFull: Liu BL
      – PersonEntity:
          Name:
            NameFull: Ge SH
      – PersonEntity:
          Name:
            NameFull: Yuan L
      – PersonEntity:
          Name:
            NameFull: Ma JH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1720-8386
          Numbering:
            – Type: volume
              Value: 48
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Journal of endocrinological investigation
              Type: main
ResultId 1